Zymeworks (ZYME) Total Liabilities (2021 - 2026)
Zymeworks' (ZYME) quarterly Total Liabilities came in at $314.6 million in Q1 2026, up 212.89% year-on-year from $100.6 million in Q1 2025, and up 303.23% quarter-over-quarter from $78.0 million in Q4 2025.
Zymeworks (ZYME) Total Liabilities (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Total Liabilities across 6 years of filings, most recently posting $314.6 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $314.6 million, up 212.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $314.6 million (up 212.89% YoY), and the FY2025 annual result was $78.0 million, down 37.24% from the prior year.
- Total Liabilities came in at $314.6 million for Q1 2026 at Zymeworks, up from $78.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $314.6 million in Q1 2026 to a low of -$282.4 million in Q1 2022.
- The 5-year median for Total Liabilities is $116.1 million (2023), against an average of $83.2 million.
- Across the five-year window, Total Liabilities tumbled 37.24% in 2025 and jumped 212.89% in 2026, its largest moves.
- Zymeworks' Total Liabilities stood at $155.8 million in 2022, then fell by 25.48% to $116.1 million in 2023, then grew by 7.11% to $124.3 million in 2024, then sank by 37.24% to $78.0 million in 2025, then surged by 303.23% to $314.6 million in 2026.
- The last three Total Liabilities figures came in at $314.6 million (Q1 2026), $78.0 million (Q4 2025), and $77.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 137.56 Mn |
| 10 | Zymeworks | 1.71 Bn | 1.35 Bn | - | 314.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 314.63 Mn |
| Dec 31, 2025 | 78.03 Mn |
| Sep 30, 2025 | 77.21 Mn |
| Jun 30, 2025 | 73.88 Mn |
| Mar 31, 2025 | 100.56 Mn |
| Dec 31, 2024 | 124.32 Mn |
| Sep 30, 2024 | 120.17 Mn |
| Jun 30, 2024 | 109.47 Mn |
| Mar 31, 2024 | 115.75 Mn |
| Dec 31, 2023 | 116.07 Mn |
| Sep 30, 2023 | 132.02 Mn |
| Jun 30, 2023 | 153.14 Mn |
| Mar 31, 2023 | 127.21 Mn |
| Dec 31, 2022 | 155.77 Mn |
| Sep 30, 2022 | 120.51 Mn |
| Jun 30, 2022 | -222.28 Mn |
| Mar 31, 2022 | -282.44 Mn |
| Dec 31, 2021 | 140.04 Mn |
| Sep 30, 2021 | -278.93 Mn |